Evidence map›Paper›PMID 40722625›Full record

ArticleBiomedicines2025

Exploring Immune Responses to SARS-CoV-2: Insights from Sinopharm (BBIBP-CorV)-Vaccinated Individuals in a Group of Venezuelan Admixed Volunteers.

Alexis Hipólito García, Soriuska José Mayora, Christian Medina, Inírida Amada Belisario, Wendy Yaqueline Martínez, Francis Isamarg Crespo, Juan Bautista De Sanctis

Abstract read
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexis Hipólito GarcíaInstitute of Immunology Nicolás Enrique Bianco, Faculty of Medicine, Universidad Central de Venezuela, Los Chaguaramos, Caracas 1040, Venezuela.ORCID 0000-0002-2354-0160
Soriuska José MayoraInstitute of Immunology Nicolás Enrique Bianco, Faculty of Medicine, Universidad Central de Venezuela, Los Chaguaramos, Caracas 1040, Venezuela.
Christian MedinaInstitute of Immunology Nicolás Enrique Bianco, Faculty of Medicine, Universidad Central de Venezuela, Los Chaguaramos, Caracas 1040, Venezuela.
Inírida Amada BelisarioInstitute of Immunology Nicolás Enrique Bianco, Faculty of Medicine, Universidad Central de Venezuela, Los Chaguaramos, Caracas 1040, Venezuela.ORCID 0000-0002-1183-3927
Wendy Yaqueline MartínezInstitute of Immunology Nicolás Enrique Bianco, Faculty of Medicine, Universidad Central de Venezuela, Los Chaguaramos, Caracas 1040, Venezuela.ORCID 0000-0002-6598-3509
Francis Isamarg CrespoInstitute of Immunology Nicolás Enrique Bianco, Faculty of Medicine, Universidad Central de Venezuela, Los Chaguaramos, Caracas 1040, Venezuela.ORCID 0000-0003-2720-0435
Juan Bautista De SanctisInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Hnevotinska 1333/5, 77900 Olomouc, Czech Republic.ORCID 0000-0002-5480-4608

Funding

Ministry of Education, Youth and Sports of the Czech Republic. Institute of Bacteriology and virology EXCELES Project No. LX22NPO5103National Fund for Science, Technology, and Innovation (FONACIT) Venezuela ACTA N° 023-2022
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cellular responsegranzyme BIFN-γinactivated virusSARS-CoV-2Sinopharm/BBIBP

Identifiers

PMID40722625
PMCPMC12293013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.